We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

TIL Therapy in Metastatic Melanoma and IL2 Dose Assessment (METILDA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01995344
Recruitment Status : Terminated (Withdrawal of funding)
First Posted : November 26, 2013
Last Update Posted : April 20, 2023
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
Christiesponsoredresearch, The Christie NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 24, 2015
Actual Study Completion Date : July 24, 2015